Literature DB >> 31463678

[Management of refractory and super-refractory status epilepticus].

Frank Erbguth1.   

Abstract

If status epilepticus continues despite the use of intravenous antiepileptic drugs or narcotics, it is called "refractory" or "super-refractory" status epilepticus (RSE, SRSE). Prolonged seizure activity is associated with neuronal damage, systemic complications and mortality rates of up to 50%, especially in generalized tonic clonic seizure types. In order to terminate the status, several rescue interventions with drugs and other measures are available. However, their evidence base is low because the effectiveness of the measures was almost exclusively derived from case reports and case series. In individual cases, a good outcome is possible even after several months of ongoing SRSE.

Entities:  

Keywords:  Antiepileptic drugs; Electroencephalography; Immunosuppression; Narcotic drugs; Seizures

Mesh:

Substances:

Year:  2019        PMID: 31463678     DOI: 10.1007/s00063-019-00610-0

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  33 in total

Review 1.  Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus.

Authors:  Sarah E Nelson; Panayiotis N Varelas
Journal:  Continuum (Minneap Minn)       Date:  2018-12

2.  Tocilizumab treatment for new onset refractory status epilepticus.

Authors:  Jin-Sun Jun; Soon-Tae Lee; Ryul Kim; Kon Chu; Sang Kun Lee
Journal:  Ann Neurol       Date:  2018-11-30       Impact factor: 10.422

Review 3.  The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol.

Authors:  Simon Shorvon; Monica Ferlisi
Journal:  Brain       Date:  2011-09-13       Impact factor: 13.501

4.  Hypothermia for Neuroprotection in Convulsive Status Epilepticus.

Authors:  Stephane Legriel; Virginie Lemiale; Maleka Schenck; Jonathan Chelly; Virginie Laurent; Fabrice Daviaud; Mohamed Srairi; Aicha Hamdi; Guillaume Geri; Thomas Rossignol; Julia Hilly-Ginoux; Julie Boisramé-Helms; Benjamin Louart; Isabelle Malissin; Nicolas Mongardon; Benjamin Planquette; Marina Thirion; Sybille Merceron; Emmanuel Canet; Fernando Pico; Yves-Roger Tran-Dinh; Jean-Pierre Bedos; Elie Azoulay; Matthieu Resche-Rigon; Alain Cariou
Journal:  N Engl J Med       Date:  2016-12-22       Impact factor: 91.245

5.  Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.

Authors:  Raoul Sutter; Stephan Marsch; Peter Fuhr; Peter W Kaplan; Stephan Rüegg
Journal:  Neurology       Date:  2013-12-06       Impact factor: 9.910

Review 6.  Outcomes of deviation from treatment guidelines in status epilepticus: A systematic review.

Authors:  Preena Uppal; Michael Cardamone; John A Lawson
Journal:  Seizure       Date:  2018-04-16       Impact factor: 3.184

Review 7.  Modern inhalational anesthetics for refractory status epilepticus.

Authors:  Frederick A Zeiler; Kaitlin J Zeiler; Jeanne Teitelbaum; Lawrence M Gillman; Michael West
Journal:  Can J Neurol Sci       Date:  2015-01-09       Impact factor: 2.104

Review 8.  A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus.

Authors:  Eugen Trinka; Hannah Cock; Dale Hesdorffer; Andrea O Rossetti; Ingrid E Scheffer; Shlomo Shinnar; Simon Shorvon; Daniel H Lowenstein
Journal:  Epilepsia       Date:  2015-09-04       Impact factor: 5.864

9.  Super-refractory status epilepticus: epidemiology, early predictors, and outcomes.

Authors:  Anne-Laure Chateauneuf; Jean-Denis Moyer; Gwenaelle Jacq; Sébastien Cavelot; Jean-Pierre Bedos; Stephane Legriel
Journal:  Intensive Care Med       Date:  2017-05-11       Impact factor: 17.440

Review 10.  Efficacy and safety of intravenous valproate for status epilepticus: a systematic review.

Authors:  Eugen Trinka; Julia Höfler; Alexander Zerbs; Francesco Brigo
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.